Bahr et al. (2019) discussed the use of intranasal esketamine (Spravato) in conjunction with oral antidepressants for the treatment of treatment-resistant depression in the journal P&T.

Authors

• Person: Not available Organization: Frontiers in Psychiatry
  The Montreal model: an integrative biomedical-psychedelic ...

Sources

• The Montreal model: an integrative biomedical-psychedelic ... www.frontiersin.org Frontiers in Psychiatry via serper

Referenced by nodes (3)

• treatment-resistant depression concept
• antidepressants concept
• esketamine concept